The effectiveness of radioiodine therapy depends on the presence of active NIS on the plasma membrane of cells.15 Low levels of NIS gene expression are often observed in patients with thyroid cancer, resulting in reduced iodine accumulation. This evidence concerns the gene SLC5A5 and thyroid cancer.